Matterworks
The Predictive Biology Company
The Predictive Biology Company
Published Aug 26, 2026
No direct, structured side-by-side customer quotes were identified in public review platforms for Pyxis; this is a gap for independent comparative evaluation.
Matterworks has published product and insight posts and appears to be actively releasing capabilities (for example, specific workflow and feature pages). The limited volume of mainstream public reviews may indicate early-stage adoption, highly enterprise/contracted deployments, or a smaller installed base; available public evidence is insufficient to determine which interpretation is correct.
| Starting Price | Not publicly listed; standard tier includes entry-level analysis credits; enterprise pricing is custom | Public procurement documents reference a Progenesis QI list price in a state contract (public contract references list pricing) | Public store listings include subscriptions and modules; pricing examples visible for some modules |
| Typical Fit | Organizations seeking a cloud-based, model-driven platform for automated MS2 identification and quantitation with a self-service entry option and negotiated enterprise pricing | Labs invested in Waters instrumentation and workflows; established commercial product and support | SCIEX instrument users needing integrated acquisition/processing and regulated workflows; vendor support available |
| Key Strength | Vendor-stated simplified upload-based workflows and model-driven spectral identification; cloud-native architecture | Mature commercial product with established vendor support and training resources | Tight coupling with instrument acquisition; commercial packaging for regulated environments |
| Key Weakness | Limited public third-party review volume; limited publicly disclosed security attestations; potential cloud governance constraints | Cost and requirement for user expertise in some workflows | Cost, potential vendor lock-in, and modular complexity |
—